HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein
<p>Abstract</p> <p>Background</p> <p>The discovery of diketoacid-containing derivatives as inhibitors of HIV-1 Integrase (IN) (IN inhibitors, IINs) has played a major role in validating this enzyme as an important target for antiretroviral therapy. Since the <it>i...
Main Authors: | Cara Andrea, Andreotti Mauro, Galluzzo Clementina, Verdoliva Antonio, Costi Roberta, Molinari Agnese, Dupuis Maria, Cianfriglia Maurizio, Di Santo Roberto, Palmisano Lucia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-03-01
|
Series: | Retrovirology |
Online Access: | http://www.retrovirology.com/content/4/1/17 |
Similar Items
-
Targeting MDR1-P-glycoprotein (MDR1-Pgp) in immunochemotherapy of acute myeloid leukemia (AML)
by: Maurizio Cianfriglia
Published: (2013-06-01) -
The biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience of gemtuzumab ozogamicin
by: Maurizio Cianfriglia
Published: (2013-06-01) -
HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.
by: Jianfang Chen, et al.
Published: (2014-01-01) -
Renal Ontogeny of P-Glycoprotein/MDR1 in Rat
by: Hodorova I., et al.
Published: (2011-03-01) -
Role of Gastrointestinal Multidrug Resistance (MDR1) Gene and P-glycoprotein (P-gp) in the Oral Absorption of Methadone in Horses
by: Linardi, Renata Lehn
Published: (2010)